1. Home
  2. CNDT vs KMDA Comparison

CNDT vs KMDA Comparison

Compare CNDT & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNDT
  • KMDA
  • Stock Information
  • Founded
  • CNDT 2016
  • KMDA 1990
  • Country
  • CNDT United States
  • KMDA Israel
  • Employees
  • CNDT N/A
  • KMDA N/A
  • Industry
  • CNDT Business Services
  • KMDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CNDT Consumer Discretionary
  • KMDA Health Care
  • Exchange
  • CNDT Nasdaq
  • KMDA Nasdaq
  • Market Cap
  • CNDT 497.6M
  • KMDA 426.0M
  • IPO Year
  • CNDT N/A
  • KMDA N/A
  • Fundamental
  • Price
  • CNDT $2.55
  • KMDA $6.28
  • Analyst Decision
  • CNDT
  • KMDA Strong Buy
  • Analyst Count
  • CNDT 0
  • KMDA 3
  • Target Price
  • CNDT N/A
  • KMDA $14.67
  • AVG Volume (30 Days)
  • CNDT 1.0M
  • KMDA 127.2K
  • Earning Date
  • CNDT 04-30-2025
  • KMDA 03-05-2025
  • Dividend Yield
  • CNDT N/A
  • KMDA 3.15%
  • EPS Growth
  • CNDT N/A
  • KMDA 66.67
  • EPS
  • CNDT 2.23
  • KMDA 0.25
  • Revenue
  • CNDT $3,356,000,000.00
  • KMDA $160,953,000.00
  • Revenue This Year
  • CNDT N/A
  • KMDA $11.45
  • Revenue Next Year
  • CNDT $1.77
  • KMDA $9.94
  • P/E Ratio
  • CNDT $1.22
  • KMDA $25.54
  • Revenue Growth
  • CNDT N/A
  • KMDA 12.93
  • 52 Week Low
  • CNDT $2.49
  • KMDA $4.74
  • 52 Week High
  • CNDT $4.90
  • KMDA $9.15
  • Technical
  • Relative Strength Index (RSI)
  • CNDT 19.52
  • KMDA 35.03
  • Support Level
  • CNDT $2.88
  • KMDA $6.44
  • Resistance Level
  • CNDT $2.76
  • KMDA $6.81
  • Average True Range (ATR)
  • CNDT 0.11
  • KMDA 0.23
  • MACD
  • CNDT -0.01
  • KMDA -0.04
  • Stochastic Oscillator
  • CNDT 9.22
  • KMDA 3.26

About CNDT Conduent Incorporated

Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: